Skip to main content

Cantor Fitzgerald Keeps Their Buy Rating on Vanda (VNDA)

Tipranks - Tipranks - Mon Feb 16, 6:26AM CST

Cantor Fitzgerald analyst Olivia Brayer maintained a Buy rating on Vanda on February 12 and set a price target of $11.00. The company’s shares closed last Friday at $6.12.

President's Day Sale - 70% Off

Brayer covers the Healthcare sector, focusing on stocks such as Vanda, CytomX Therapeutics, and Insmed. According to TipRanks, Brayer has an average return of 6.7% and a 46.15% success rate on recommended stocks.

Currently, the analyst consensus on Vanda is a Strong Buy with an average price target of $13.63.

See the top stocks recommended by analysts >>

Based on Vanda’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $56.26 million and a GAAP net loss of $22.59 million. In comparison, last year the company earned a revenue of $47.65 million and had a GAAP net loss of $5.32 million

Read More on VNDA:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).